Get the latest tech news
New schizophrenia drug improves symptoms current drugs can’t touch | A novel drug, Evenamide, quieted overactive brain circuits in an animal model of schizophrenia, improving memory, social interaction, and dopamine balance.
A novel drug, evenamide, quieted overactive brain circuits in an animal model of schizophrenia, improving memory, social interaction, and dopamine balance, offering hope for tackling symptoms that current antipsychotics can’t touch.
A novel drug, evenamide, quieted overactive brain circuits in an animal model of schizophrenia, improving memory, social interaction, and dopamine balance, offering hope for tackling symptoms that current antipsychotics can’t touch. “This represents a significant advancement in treatment, as evenamide can downregulate the hyperdopaminergic state without producing D2 blockade-related side effects while also improving behavioral deficits that are not properly treated by D2 blocking antipsychotic agents.” “The preclinical and clinical results suggest [a] high likelihood of success for our ongoing pivotal Phase III program and potentially offering a completely new treatment paradigm to patients with schizophrenia.”
Or read this on r/tech